Skip to main content

Caribou Biosciences, Inc.

corporate_fare Company Profile

Caribou Biosciences, Inc.

CRBU·NASDAQ·Life Sciences·CIK 0001619856

The company is a clinical-stage biopharmaceutical company focused on developing transformative therapies for patients with devastating diseases using CRISPR genome-editing technology. Its genome-editing platform utilizes novel chRDNA (CRISPR hybrid RNA-DNA) technology, which aims to enable more precise genome editing of allogeneic cell therapies. The company's allogeneic, or off-the-shelf, chimeric antigen receptor (CAR)-T cell therapy product candidates are manufactured in advance using cells from healthy donors. These candidates are directed at CD19 and B cell maturation antigen (BCMA), which are established cell surface targets. The chRDNA technology is used to enhance the activity of cell therapy product candidates against hematologic malignancies through genome-editing strategies like checkpoint disruption and immune cloaking. The company is advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for hematologic malignancies: Vispacabtagene regedleucel (vispa-cel, formerly CB-010), an allogeneic anti-CD19 CAR-T cell therapy, has been evaluated in patients with relapsed or refractory B cell non-Hodgkin lymphoma (r/r B-NHL) in the ANTLER phase 1 clinical trial. CB-011, an allogeneic anti-BCMA CAR-T cell therapy, is being evaluated in patients with relapsed or refractory multiple myeloma (r/r MM) in the CaMMouflage phase 1 clinical trial. Vispa-cel has received regenerative medicine advanced therapy (RMAT) designation for relapsed or refractory large B cell lymphoma (r/r LBCL), fast track designation for r/r B-NHL, and orphan drug designation for follicular lymphoma (FL) from the U.S. Food and Drug Administration (FDA).

Caribou Biosciences, Inc. (NASDAQ:CRBU) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 16 items for CRBU at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for CRBU spans 10-Q, 8-K, PRE 14A, 10-K.

Recent high-impact activity:

  • Caribou 10-Q: $94.8M Cash, $26.6M Q3 Loss, Nasdaq Bid-Price Deficiency Disclosed
  • Caribou Posts Q3 Loss of $26.6M, Cash Falls to $94.8M Amid Strategic Review
  • Caribou Halts Lead CAR-T Programs, CFO to Exit as Strategic Review Begins
  • Caribou Halts Lead CAR-T Programs, Explores Strategic Alternatives
  • Caribou Halts CAR-T Programs, Cuts Workforce, and Explores Sale

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$11.16M
Net Income
-$148.13M
Diluted EPS
-$1.59
Op. Cash Flow
-$110.99M
Free Cash Flow
-$112.35M
Operating Income
-$148.34M
Cash & Equivalents
$12.36M
Debt / Equity
0.00×
Net Margin
-13.27×
Shares Outstanding
95.14M sh
Source: 10-K · filed 2026-03-05 · accession 0001619856-26-000008

Short Interest & Short Volume

6.04 days to cover

FINRA reported short interest of 14,892,848 shares in CRBU as of the October 30, 2026 settlement, a 18.6% increase from the prior period — about 6.0 days to cover at its recent average daily volume. On November 20, 2026, 45.7% of CRBU volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)14,892,848 shares as of October 30, 2026
Change vs prior period▲ 18.6%
Days to cover6.04 at avg daily volume of 2,467,710
Daily short volume (FINRA facilities)45.7% of 2,107,701 shares on November 20, 2026
5-day average short volume53.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$0.2843
52-week range · as of 2026-11-05 $0.2843 – $2.49
Market cap
$30.71M
Volume
3.3M (1.3× avg)
3-mo avg 2.6M
Live data · 2026-11-21 08:46 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CRBU - Latest Insights

CRBU
Nov 05, 2026, 4:08 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.405
Real-time Price: $0.2843 info
Change: -$0.1207 (-30%) info
Market Cap: $30.715M info
CRBU
Nov 05, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.405
Real-time Price: $0.2843 info
Change: -$0.1207 (-30%) info
Market Cap: $30.715M info
CRBU
Oct 06, 2026, 4:37 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.705
Real-time Price: $0.2843 info
Change: -$0.4207 (-60%) info
Market Cap: $30.715M info
CRBU
Oct 06, 2026, 4:11 PM EDT
Source: Seeking Alpha
Importance Score:
9
Price at Filing: $1.14
Real-time Price: $0.2843 info
Change: -$0.8507 (-75%) info
Market Cap: $30.715M info
CRBU
Oct 06, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.14
Real-time Price: $0.2843 info
Change: -$0.8507 (-75%) info
Market Cap: $30.715M info
CRBU
Aug 13, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.61
Real-time Price: $0.2843 info
Change: -$1.33 (-82%) info
Market Cap: $30.715M info
CRBU
Aug 13, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.62
Real-time Price: $0.2843 info
Change: -$1.34 (-82%) info
Market Cap: $30.715M info
CRBU
Jun 18, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.64
Real-time Price: $0.2843 info
Change: -$1.36 (-83%) info
Market Cap: $30.715M info
CRBU
Jun 11, 2026, 8:13 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.81
Real-time Price: $0.2843 info
Change: -$1.53 (-84%) info
Market Cap: $30.715M info
CRBU
Jun 11, 2026, 8:02 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.73
Real-time Price: $0.2843 info
Change: -$1.44 (-84%) info
Market Cap: $30.715M info
CRBU
May 07, 2026, 4:32 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.87
Real-time Price: $0.2843 info
Change: -$1.59 (-85%) info
Market Cap: $30.715M info
CRBU
May 07, 2026, 4:14 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.87
Real-time Price: $0.2843 info
Change: -$1.59 (-85%) info
Market Cap: $30.715M info
CRBU
Apr 10, 2026, 4:01 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $1.93
Real-time Price: $0.2843 info
Change: -$1.65 (-85%) info
Market Cap: $30.715M info
CRBU
Mar 31, 2026, 8:02 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.86
Real-time Price: $0.2843 info
Change: -$1.57 (-85%) info
Market Cap: $30.715M info
CRBU
Mar 05, 2026, 4:13 PM EST
Source: Reuters
Importance Score:
8
Price at Filing: $1.75
Real-time Price: $0.2843 info
Change: -$1.47 (-84%) info
Market Cap: $30.715M info
CRBU
Mar 05, 2026, 4:09 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.76
Real-time Price: $0.2843 info
Change: -$1.48 (-84%) info
Market Cap: $30.715M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets